The biotechnology company intends to more than double its current production capacity at the Navy Yard, interim CEO Fred Vogt ...

Use of nivolumab (Opdivo) before chemotherapy was not associated with improved pathologic complete response (pCR) rates among ...

Deborah S. Sarnoff, M.D., talks about the recent breakthrough treatments that are paving the way to treat patients with ...

Immunotherapy advances in triple-negative breast cancer drive personalized treatments with immune checkpoint inhibitors, aiding subtype identification and new combination therapy developments.

PhD Defense: Predicting immunotherapy outcomes in advanced melanoma; Clinical, radiological, and pathological approaches ...

By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. You accept for the main domain ...

DelveInsight’s, “Mesothelioma Pipeline Insight 2025” report provides comprehensive insights about 45+ companies and 50+ ...

Immuno-oncology and cell-based treatments, which harness the body's own immune system to combat illnesses like cancer, have ...

KSQ Therapeutics, Inc. (KSQ), a clinical-stage biotechnology company developing novel treatments for solid tumors, including ...

Cell and gene therapies have undergone notable milestones in the last 12 months, with solid tumors and diabetes treatments.

SUZHOU, China I March 3, 2025 I CStone Pharmaceuticals ("CStone", HKEX: 2616), an innovation-driven biopharmaceutical company focused on the research and ...